<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: A multicenter, prospective cohort study</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Jan</forename><forename type="middle">N</forename><surname>Bouwes Bavinck</surname></persName>
							<email>j.n.bouwes_bavinck@lumc.nl</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">Leiden University Medical Center</orgName>
								<address>
									<settlement>Leiden</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">|</forename><surname>Mariet</surname></persName>
						</author>
						<author>
							<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Feltkamp</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Medical Microbiology</orgName>
								<orgName type="institution">Leiden University Medical Center</orgName>
								<address>
									<settlement>Leiden</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Adele</forename><forename type="middle">C</forename><surname>Green</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">QIMR Berghofer Medical Research Institute</orgName>
								<address>
									<settlement>Brisbane</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marta</forename><surname>Fiocco</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Medical Statistics and Bioinformatics</orgName>
								<orgName type="institution">Leiden University Medical Center</orgName>
								<address>
									<settlement>Leiden</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Institute of Mathematics</orgName>
								<orgName type="institution">Leiden University</orgName>
								<address>
									<settlement>Leiden</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sylvie</forename><surname>Euvrard</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">Edouard Herriot Hospital</orgName>
								<address>
									<addrLine>Hospices Civils de Lyon</addrLine>
									<settlement>Lyon</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Catherine</forename><forename type="middle">A</forename><surname>Harwood</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">The London School of Medicine and Dentistry</orgName>
								<orgName type="laboratory">Centre for Cell Biology and Cutaneous Research</orgName>
								<orgName type="institution">Blizard Institute</orgName>
								<address>
									<addrLine>Barts</addrLine>
									<region>Queen</region>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="institution">Mary University of London</orgName>
								<address>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Shaaira</forename><surname>Nasir</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">The London School of Medicine and Dentistry</orgName>
								<orgName type="laboratory">Centre for Cell Biology and Cutaneous Research</orgName>
								<orgName type="institution">Blizard Institute</orgName>
								<address>
									<addrLine>Barts</addrLine>
									<region>Queen</region>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="institution">Mary University of London</orgName>
								<address>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jason</forename><forename type="middle">]</forename><surname>Thomson</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">The London School of Medicine and Dentistry</orgName>
								<orgName type="laboratory">Centre for Cell Biology and Cutaneous Research</orgName>
								<orgName type="institution">Blizard Institute</orgName>
								<address>
									<addrLine>Barts</addrLine>
									<region>Queen</region>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="institution">Mary University of London</orgName>
								<address>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Charlotte</forename><forename type="middle">M</forename><surname>Proby</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Division of Cancer Research</orgName>
								<orgName type="institution" key="instit1">University of Dundee</orgName>
								<orgName type="institution" key="instit2">Ninewells Hospital and Medical School</orgName>
								<address>
									<settlement>Dundee</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Luigi</forename><surname>Naldi</surname></persName>
							<affiliation key="aff9">
								<orgName type="department" key="dep1">Department of Dermatology</orgName>
								<orgName type="department" key="dep2">GISED Study Center</orgName>
								<orgName type="institution">Azienda Ospedaliera papa Giovanni XXIII</orgName>
								<address>
									<settlement>Bergamo</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">|</forename><surname>Janouk</surname></persName>
						</author>
						<author>
							<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Diphoorn</surname></persName>
							<affiliation key="aff9">
								<orgName type="department" key="dep1">Department of Dermatology</orgName>
								<orgName type="department" key="dep2">GISED Study Center</orgName>
								<orgName type="institution">Azienda Ospedaliera papa Giovanni XXIII</orgName>
								<address>
									<settlement>Bergamo</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anna</forename><surname>Venturuzzo</surname></persName>
							<affiliation key="aff9">
								<orgName type="department" key="dep1">Department of Dermatology</orgName>
								<orgName type="department" key="dep2">GISED Study Center</orgName>
								<orgName type="institution">Azienda Ospedaliera papa Giovanni XXIII</orgName>
								<address>
									<settlement>Bergamo</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gianpaolo</forename><surname>Tessari</surname></persName>
							<affiliation key="aff10">
								<orgName type="department" key="dep1">Department of Medicine</orgName>
								<orgName type="department" key="dep2">Section of Dermatology</orgName>
								<orgName type="institution">University of Verona</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ingo</forename><surname>Nindl</surname></persName>
							<affiliation key="aff12">
								<orgName type="department" key="dep1">Department of Dermatology</orgName>
								<orgName type="department" key="dep2">Skin Cancer Center Charité</orgName>
								<orgName type="institution">University Hospital Charité</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Francesca</forename><surname>Sampogna</surname></persName>
							<affiliation key="aff13">
								<orgName type="department">Clinical Epidemiology Unit</orgName>
								<orgName type="institution">IDI-IRCCS FLMM</orgName>
								<address>
									<settlement>Rome</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">|</forename><surname>Damiano</surname></persName>
							<affiliation key="aff13">
								<orgName type="department">Clinical Epidemiology Unit</orgName>
								<orgName type="institution">IDI-IRCCS FLMM</orgName>
								<address>
									<settlement>Rome</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rachel</forename><forename type="middle">E</forename><surname>Neale</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">QIMR Berghofer Medical Research Institute</orgName>
								<address>
									<settlement>Brisbane</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jelle</forename><forename type="middle">J</forename><surname>Goeman</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Medical Statistics and Bioinformatics</orgName>
								<orgName type="institution">Leiden University Medical Center</orgName>
								<address>
									<settlement>Leiden</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">|</forename><surname>Koen</surname></persName>
						</author>
						<author>
							<persName><forename type="first">D</forename><surname>Quint</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">Leiden University Medical Center</orgName>
								<address>
									<settlement>Leiden</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anne</forename><forename type="middle">Berthe</forename><surname>Halk</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">Leiden University Medical Center</orgName>
								<address>
									<settlement>Leiden</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carmen</forename><surname>Sneek</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">Leiden University Medical Center</orgName>
								<address>
									<settlement>Leiden</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Roel</forename><forename type="middle">E</forename><surname>Genders</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">Leiden University Medical Center</orgName>
								<address>
									<settlement>Leiden</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maurits</forename><forename type="middle">N C</forename><surname>De Koning</surname></persName>
							<affiliation key="aff14">
								<orgName type="institution">DDL Diagnostic Laboratory</orgName>
								<address>
									<settlement>Rijswijk</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">|</forename><surname>Wim</surname></persName>
						</author>
						<author>
							<persName><forename type="first">G</forename><forename type="middle">V</forename><surname>Quint</surname></persName>
							<affiliation key="aff14">
								<orgName type="institution">DDL Diagnostic Laboratory</orgName>
								<address>
									<settlement>Rijswijk</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ulrike</forename><surname>Wieland</surname></persName>
							<affiliation key="aff15">
								<orgName type="department">Institute of Virology</orgName>
								<orgName type="institution">University of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sönke</forename><surname>Weissenborn</surname></persName>
							<affiliation key="aff15">
								<orgName type="department">Institute of Virology</orgName>
								<orgName type="institution">University of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tim</forename><surname>Waterboer</surname></persName>
							<affiliation key="aff16">
								<orgName type="department">German Cancer Research Center (DKFZ)</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Pawlita</surname></persName>
							<affiliation key="aff16">
								<orgName type="department">German Cancer Research Center (DKFZ)</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Herbert</forename><surname>Pfister</surname></persName>
							<affiliation key="aff15">
								<orgName type="department">Institute of Virology</orgName>
								<orgName type="institution">University of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jan</forename><surname>Nico</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Bouwes</forename><surname>Bavinck</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Mariet</forename><forename type="middle">C W</forename><surname>Feltkamp</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Damiano</forename><surname>Abeni</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Wim</forename><forename type="middle">G V</forename><surname>Quint</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Janouk</forename><forename type="middle">C D</forename><surname>Diphoorn</surname></persName>
						</author>
						<author>
							<affiliation key="aff11">
								<orgName type="institution">Ospedale Civile Maggiore</orgName>
								<address>
									<settlement>Verona</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff17">
								<orgName type="institution">Italian Ministry of Health</orgName>
								<address>
									<settlement>Rome</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff18">
								<orgName type="institution">BOUWES BAVINCK Et Al</orgName>
							</affiliation>
						</author>
						<title level="a" type="main">Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: A multicenter, prospective cohort study</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">8362C6AEE2B07CD55185BD0C0AD5F755</idno>
					<idno type="DOI">10.1111/ajt.14537</idno>
					<note type="submission">Received: 7 July 2017 | Revised: 20 September 2017 | Accepted: 3 October 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:14+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>CI, confidence interval</term>
					<term>BCC, basal cell carcinoma</term>
					<term>PV, papillomavirus</term>
					<term>cSCC, cutaneous squamous cell carcinoma</term>
					<term>HPV, human papillomavirus</term>
					<term>HR, hazard ratio</term>
					<term>OTR, organ transplant recipient</term>
					<term>UVR, ultraviolet radiation</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Members of the EPI-HPV-UV-CA group are listed in the Appendix.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1">| INTRODUCTION</head><p><s>Cutaneous squamous cell carcinoma (cSCC) is the most common malignancy in solid organ transplant recipients (OTRs), followed by basal cell carcinoma (BCC). <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref></s><s>The incidence of cSCC and BCC increases with duration of immunosuppressive therapy. <ref type="bibr" target="#b0">1</ref> Important risk factors are male sex, increasing age, fair skin type, sun exposure, and smoking. <ref type="bibr" target="#b2">3</ref></s><s>CCs are usually preceded by multiple viral warts from human papillomavirus (HPV) infection and by actinic keratoses, which also often contain HPV. <ref type="bibr" target="#b2">3</ref> The virome component of the human microbiome is known to play an important role in disease, <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b4">5</ref> and HPV is particularly prevalent in the normal skin virome. <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b6">7</ref></s><s>HPVs are double-stranded DNA viruses that are classified into 5 genera (α, β, γ, μ, and ν). <ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b8">9</ref></s><s>αHPVs (eg, mucosal HPV types 16 and 18) are responsible for the development of cervical carcinoma and other mucosal SCCs, including anogenital and oropharyngeal carcinomas. <ref type="bibr" target="#b9">10</ref></s><s>4]<ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref> βPV cause latent, persistent skin infections <ref type="bibr" target="#b17">18</ref> and were first discovered in cSCCs from patients with epidermodysplasia verruciformis, a rare genetic skin disease characterized by increased susceptibility to βPV with a high risk of cSCC on sun-exposed skin. <ref type="bibr" target="#b8">9</ref></s><s>Vs are ubiquitous, with more than 90% of people carrying these viruses as part of their normal skin virome. <ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b19">20</ref></s><s>Hair follicles are the likely reservoir. <ref type="bibr" target="#b17">18</ref></s><s>βPV-infected cells may have impaired DNA repair and decreased sensitivity to apoptosis induced by ultraviolet radiation (UVR), facilitating escape from normal cellular defense mechanisms. <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b12">13</ref></s><s>substantial body of epidemiologic data show an association between HPV infection and cSCC, <ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref> in particular, in OTRs. <ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b25">26</ref></s><s><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref> Case-control studies in both OTR and immunocompetent populations have shown that the presence of βPV DNA or antibodies was associated with a 1.5-to 3-fold increased risk of cSCC.</s><s><ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b31">32</ref> It was not possible, however, to determine whether the βPV infection increases risk of cSCC development or whether cSCC formation promotes active proliferation of βPV.</s><s>To our best knowledge, there is only 1 published cohort study in OTRs that investigated the influence of βPV infection on the development of cSCC.</s><s><ref type="bibr" target="#b25">26</ref> In a single-center study in 445 patients, OTRs who were βPV seropositive around the time of transplantation had an almost 3-fold increased risk of developing cSCC during the 22-year follow-up period. <ref type="bibr" target="#b25">26</ref> There are n</s><s>rospective studies in which the associations between cSCC and both the number and DNA load of βPV types have been examined.</s></p><p><s>In this study, we present data from 2 prospective multicenter cohort studies confirming that the presence of human skin βPV infection is associated with cSCC development in OTRs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2">| METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1">| Participants and study design</head><p><s>As part of a European Union-funded fifth framework program (5FP) collaborative research grant (QLK2-CT-2002-0117), the EPI-HPV-UV-CA study group collected data for a prospective <ref type="bibr" target="#b34">35</ref> and a case-control study between 2003 and 2006. <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b24">25</ref></s><s>A description of the inclusion and exclusion criteria is provided in the supplementary material (Figures <ref type="figure" target="#fig_2">S1A-S1C</ref>).</s><s>Cohort 1 was assembled from 441 OTRs followed until death or cessation of follow-up in 2016.</s><s>βPV infection was assessed in eyebrow hair by using polymerase chain reaction-based methods.</s><s>βPV IgG seroresponses were determined with multiplex serology.</s><s>A competing risk model with delayed entry was used to estimate cumulative incidence of histologically proven cSCC and the effect of βPV by using a multivariable Cox regression model.</s><s>Results are reported as adjusted hazard ratios (HRs).</s><s>OTRs with 5 or more different βPV types in eyebrow hair had 1.7 times the risk of cSCC vs OTRs with 0 to 4 different types (HR 1.7, 95% confidence interval 1.1-2.6).</s><s>A similar risk was seen with high βPV loads (HR 1.8, 95% confidence interval 1.2-2.8).</s><s>No significant associations were seen between serum antibodies and cSCC or between βPV and basal cell carcinoma.</s><s>The diversity and load of βPV types in eyebrow hair are associated with cSCC risk in OTRs, providing evidence that βPV is associated with cSCC carcinogenesis and may present a target for future preventive strategies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>K E Y W O R D S</head><p><s>cancer/malignancy/neoplasia: risk factors, cancer/malignancy/neoplasia: skin -nonmelanoma, clinical research/practice, infection and infectious agents -viral, infection and infectious agents -viral: papillomavirus, organ transplantation in general who participated in the prospective study. <ref type="bibr" target="#b34">35</ref></s><s>Of these, 167 were excluded due to lack of sufficient follow-up data, leaving a final cohort of 274 OTRs.</s><s>Cohort 2 was established from 915 OTRs who participated in the case-control study. <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b24">25</ref></s><s>Exclusion of OTRs with lack of sufficient follow-up data (n = 242), an cSCC diagnosed before recruitment (n = 210), or transplanted before 1986 (n = 111) gave a total of 352 OTRs.</s><s>Both cohorts were under prospective observation until 2016.</s></p><p><s>Between 2003 and 2006, relevant demographic data and information about skin cancer risk factors were collected. <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b34">35</ref></s><s>Plucked eyebrow hair was collected; DNA was extracted for detection and genotyping of 25 βPV types using the skin βPV prototype research assay (Labo Bio-medical Products BV, Rijswijk, The Netherlands) <ref type="bibr" target="#b35">36</ref> and for viral load determination using quantitative polymerase chain reaction. <ref type="bibr" target="#b31">32</ref></s><s>Because more than 95% of OTRs had 1 or more βPV types in their eyebrow hair, <ref type="bibr" target="#b24">25</ref> we dichotomized the number of βPV as 0 to 4 and as 5 or more, as previously published. <ref type="bibr" target="#b24">25</ref></s><s>High viral load was defined as 1 βPV copy per 1 to 19 cells and low load as 1 copy per 20 or more cells.</s><s>Serum was collected and tested for 16 βPV, 6 γPV, 4 αPV, 2 μPV, and 1 νPV IgG antibodies with a multiplex serology technique based on glutathione s-transferase capture ELISA in combination with fluorescent bead technology. <ref type="bibr" target="#b36">37,</ref><ref type="bibr" target="#b37">38</ref></s><s><ref type="bibr" target="#b36">[37]</ref><ref type="bibr" target="#b37">[38]</ref> In cohort 1, eyebrow hair and serum were collected at 1, 3, 6, 9, 12, and 18 months posttransplantation.</s><s>The 12-month posttransplantation time point was selected for the final analyses, because this time point best represented the βPV DNA measurement, as separate analyses have shown (Figures <ref type="figure" target="#fig_0">S2A and S2B</ref>).</s><s>No participants had developed cSCC before this time point.</s><s>In cohort 2, DNA and serum were collected at the time of recruitment, a median of 10 (range 2-19) years after transplantation.</s><s>This was assumed to be representative of βPV DNA status in the years before sampling as βPV infection is characterized by a chronic persistent course with βPV DNA content in eyebrow hair being stable over time. <ref type="bibr" target="#b17">18</ref></s><s>l OTRs were routinely seen 1 to 4 times per year in specialized centers dedicated to surveillance of OTRs with skin lesions.</s><s>Clinical information was collected from the time of enrolment between 2003 and 2006 until the last follow-up in 2016 and included the first histologically confirmed cSCC and BCC and the date of the last follow-up or death.</s><s>We used medical charts, local pathology records, and local oncology databases to collect this information.</s><s>Both cohort studies adhered to the Declaration of Helsinki principles, and the local medical ethical committees of the hospitals in the participating countries had approved the study design.</s><s>A competing risk model with death as competing event and delayed entry (also referred to as left truncation) was used to estimate the cumulative incidence of first cSCC or BCC since transplantation. <ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b39">40</ref></s><s>Competing risk models take into account situations where more than 1 cause of failure is possible.</s><s>In our study, the 2 competing events were cSCC or BCC and death, as patients might have died beforethe occurrence of cSCC or BCC.</s><s>Delayed entry was used to adjust for the fact that in cohort 2 the HPV DNA testing and serology were not performed at the time of transplantation and that we had taken the 12-month time point in cohort 1.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2">| Statistical analysis</head><p><s>We had previously defined a new variable based on concordance of βPV DNA and serology.</s><s>We classified OTR according to whether they were both antibody and DNA positive for the same βPV type as follows: antibody negative, regardless of DNA status; antibody positive but with no types for which DNA was also found; and antibody positive with at least 1 type concordant for DNA. <ref type="bibr" target="#b24">25</ref> The final analyses were adjusted for sex, age, skin type, and study center (study center being an important composite variable representing differences in patient populations, immunosuppression regimens, and sun exposure between the 3 clinical sites).</s><s>We also investigated the other clinical variables, and none changed the estimates of interest.</s><s>These were, therefore, not included in the analysis.</s><s>Analyses of cohort 2 or of the combined cohorts showed that adjustment for type of immunosuppression, type of organ transplanted, average sun exposure, number of sunburns, smoking, or alcohol consumption did not substantially change the hazard ratios (HRs) (data not shown).</s><s>We did not adjust for keratotic skin lesions and common viral warts, as these potentially lie on the causal pathway between HPV infection and cSCC or BCC and their inclusion in the model may lead to overadjustment, biasing the result toward the null. <ref type="bibr" target="#b40">41</ref></s><s>e analyses concerning the competing risk model were performed in R environment (http://www.R-project.org) with the mstate library. <ref type="bibr" target="#b41">42</ref></s><s>All other analyses were performed with SPSS Statistics for Windows version 23.0 (IBM Corp., Armonk, NY).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3">| RESULTS</head><p><s>The median and maximum follow-up times since transplantation were 9.5 and 12.4 years in cohort 1 and 18.7 and 29.9 years in cohort 2, respectively.</s><s>The median and maximum follow-up times since DNA and serum sampling did not differ between the cohorts and were 9.</s><s>The clinical profile of transplanted patients differed between cohorts 1 and 2 (Table <ref type="table">1</ref>), but there were no significant differences in virologic results and association with cSCC.</s><s>OTRs in cohort 1 were more often female, had a darker skin type, were less often smokers, and had lower alcohol consumption.</s><s>Almost all received mycophenolate mofetil in combination with tacrolimus, rather than azathioprine, which was the main immunosuppressive drug in cohort 2. The numbers of keratotic lesions and common viral warts were higher in cohort 2, consistent with their longer duration of immunosuppression (Table <ref type="table">1</ref>).</s></p><formula xml:id="formula_0">T A B L E</formula><p><s>(Continues) majority (&gt;80%) of both cohorts were kidney transplant recipients, we had insufficient statistical power to assess differences in risk of cSCC according to type of organ transplant received.</s><s>As we have reported earlier, <ref type="bibr" target="#b2">3</ref> the number of keratotic skin lesions and common viral warts was strongly associated with the development of cSCC, with an adjusted HR of 4.7 (95% confidence interval [CI] 2.0-10.9)</s><s>for OTRs with 50 or more lesions compared with those OTRs with fewer lesions.</s></p><p><s>After adjustment, sun exposure, painful sunburns, and smoking were not associated with cSCC in the combined cohort (Table <ref type="table" target="#tab_1">2</ref>).</s></p><p><s>The number of βPV types in eyebrow hair, βPV DNA load, and serologic responses to HPV did not significantly differ between the 2 cohorts (Table <ref type="table">1</ref>).</s><s>Figure <ref type="figure" target="#fig_2">1</ref> shows a higher overall cumulative incidence of cSCC in OTRs infected with multiple (≥5) HPV types measured 12 months posttransplantation in cohort 1 and after a median of 10 years posttransplantation in cohort 2 compared with OTR with fewer βPV types or noninfected OTRs (Figure <ref type="figure" target="#fig_2">1A</ref>).</s><s>The cumulative incidence of cSCC for the separate cohorts is provided in Figures <ref type="figure">S3A and   S3B</ref>.</s><s>Table <ref type="table">3</ref> reports the association between presence of βPV DNA in eyebrow hair and subsequent development of cSCC.</s><s>The combined adjusted HR was 1.7 (95% CI 1.1-2.6).</s><s>More detailed information is provided in the Tables S3-S5.</s></p><p><s>High βPV load was also associated with a significantly higher cumulative incidence of cSCC compared with a low load or absent βPV types (Figure <ref type="figure" target="#fig_2">1B</ref> and Table <ref type="table">3</ref>).</s><s>In the combined cohort, the adjusted HR was 1.8 (95% CI 1.2-2.8).</s><s>The βPV load risk factor in cohort 1 was probably driving the HRs in the combined analyses.</s></p><p><s>HPV seropositivity at the time of sampling was not associated with cSCC risk (Figures <ref type="figure" target="#fig_2">1C and 1D</ref> and Table <ref type="table">3</ref>).</s><s>The association was stronger but still not significant for concordant serologic responses (Figure <ref type="figure" target="#fig_2">1D</ref> and Table <ref type="table">3</ref>).</s><s>We observed a weak association between γPV seropositivity and cSCC (Table <ref type="table">3</ref>) but no association with αPV, μPV, and νPV seropositivity (Tables <ref type="table">S3-S5</ref>).</s><s>We examined possible heterogeneity of βPV effects between cohorts 1 and 2, but this was not the case in the univariate and adjusted analyses for any of the variables in Table <ref type="table">3</ref>.</s><s>We were unable to assess the influence of type of organ transplanted because our study populations were mostly kidney transplant recipients.</s><s>There was no evidence of violation of the proportional hazard assumption.</s></p><p><s>Data on individual HPV types suggested that βPV of species 1, specifically HPV types 5, 8, 20, 21, and 36, are those most likely to be involved in cutaneous squamous carcinogenesis, with possible roles for HPV76 (species 3) and HPV92 (species 4) (Table <ref type="table">S6</ref>).</s><s>The increased risk of skin cancer was specific for cSCC; there were no statistically significant associations between HPV infection and the development of BCC (Table <ref type="table">S7</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4">| DISCUSSION</head><p><s>In this observational hospital-based study of 2 OTR cohorts with a follow-up period after HPV sampling of longer than 10 years, we found that the diversity and load of infecting βPV types were associated with an approximately doubled risk of cSCC.</s><s>Our results were robust after adjustment for multiple potential confounders.</s><s>This level of increased risk is equivalent to that associated with other well-established risk factors such as skin phototype 3 and points to an important role for the skin virome and specifically HPV in the pathogenesis of cSCC.</s></p><p><s>HPV constitute an important part of the normal human skin virome. <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b19">20</ref></s><s>There is strong evidence from laboratory studies to suggest</s></p><p><s>All hazard ratios (HRs) are calculated using delayed entry and adjusting for competitive risk of death.</s><s>Significant HRs are indicated in bold.</s><s>Aza, azathioprine; CyA, cyclosporin A; MMF, mycophenolate mofetil; SCC, squamous cell carcinoma; Tac, tacrolimus.</s></p><p><s>a</s></p><p><s>The adjusted HRs are calculated with the factor of interest and sex, age at physical examination, skin type, and study center included in the model.</s><s>4]<ref type="bibr" target="#b14">[15]</ref> In normal cells, UVR upregulates cellular defense processes leading to p53 activation, cell cycle arrest, apoptosis, or DNA repair.</s><s>Several βPV types (eg, HPV5, HPV8, HPV38, and HPV49) deregulate these crucial cellular regulatory pathways by targeting multiple transcription factors and/or transcriptional regulators, resulting in infected cells that are highly susceptible to chromosomal instability and malignant transformation by UVR. <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b42">43</ref></s><s>Synergy between βPV and UVR has also been documented in animal models.</s><s>In transgenic mice expressing the HPV8 early region or E6 gene alone, a single dose of UVR rapidly promoted papillomas and cSCC formation, <ref type="bibr" target="#b15">16</ref> and in HPV38</s></p><p><s>E6/E7 transgenic mice, UVR also induced the development of actinic keratoses and cSCC. <ref type="bibr" target="#b16">17</ref></s><s>Certain βPV types also appear to have enhanced replication in the context of host immunosuppression, likely accompanied by increased oncogene expression and oncogenic activity. <ref type="bibr" target="#b43">44</ref></s><s>evious epidemiologic studies investigating the association between βPV and cutaneous squamous carcinogenesis have generated inconsistent findings. <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b11">12</ref></s><s>One of the challenges is the diversity of recognized HPV types within the normal skin virome. <ref type="bibr" target="#b32">33,</ref><ref type="bibr" target="#b33">34</ref></s><s>More than 200 HPV types have been identified, and the number of putative new types is increasing. <ref type="bibr" target="#b32">33,</ref><ref type="bibr" target="#b33">34,</ref><ref type="bibr" target="#b44">45</ref></s><s>We tested for only a subset of HPV types.</s><s>Our polymerase chain reaction-based βPV DNA detection technique was state-of-theart when we initiated this study and remains a reliable and reproducible method.</s><s>It is possible, however, that the true association between βPV infection and cSCC is even stronger, as we may have failed to detect additional relevant HPV infections.</s><s>We also observed that seropositivity to γPV was associated with subsequent cSCC, supporting recent findings that γPV type HPV197 is commonly present in skin tumors <ref type="bibr" target="#b33">34</ref> and that its E6 and E7 proteins interact with a set of cellular proteins similar to those encoded by genital HPVs linked to human carcinogenesis. <ref type="bibr" target="#b44">45</ref></s><s>other limitation of this study was the lack of follow-up data in Berlin and Verona.</s><s>While this decreased the power of the study, we believe that it is unlikely to have introduced bias because all patients in these 2 centers were excluded, independent of their medical history.</s></p><p><s>Although cohort 1 was ideally designed for analysis of the involvement of HPV in cSCC development, we were hampered by the low number of events during the first 10 years after transplantation.</s><s>Therefore, cohorts 1 and 2 were combined, which in the crude associations between the presence, number, and load of βPV DNA with the later development of cSCC appeared similar.</s><s>There were also differences between the 2 cohorts.</s><s>In recent years, older patients were more frequently transplanted, the immunosuppressive regimen changed, and a larger proportion of patients with a darker skin phototype were transplanted, especially in Leiden and London.</s></p><p><s>Other potential limitations of this study are missing data in the clinical characteristics included in the multivariable analyses.</s><s>Of All hazard ratios (HRs) are calculated using delayed entry and adjusting for competitive risk of death.</s><s>Significant HRs are indicated in bold.</s></p><p><s>a</s></p><p><s>The detailed numbers of squamous cell carcinoma per cohort and per exposure are provided in the supplementary material (Tables <ref type="table">S3-S5</ref>).</s></p><p><s>b Adjusted HRs are not available for cohort 1 because of low number of events.</s><s>c The HRs are adjusted for sex, age at physical examination, skin type, and study center.</s></p><p><s>particular concern is the 28% missing data for alcohol consumption, but we found no evidence that adjusting for alcohol in those with complete information made any difference to the estimates of association between HPV and cSCC.</s><s>We have no good explanation why we did not find a statistically significant association with βPV serology.</s><s>We have shown a 40% increased risk of cSCC overall in seropositive OTRs but had to exclude a substantial number of patients because of missing data, decreasing the power of our study, which may be a possible explanation of our failure to show a statistically significant association between βPV serology and cSCC.</s></p><p><s>This cohort study provides evidence that infection with βPV is associated with the development of cSCC.</s><s>βPV vaccines are now in development, and our data provide a rationale for routine pretransplantation screening of the skin virome for βPV content and βPV vaccination of high-risk individuals as a possible future strategy for reducing the burden of posttransplantation cSCC.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Cohorts 1 and 2</head><label>2</label><figDesc><div><p><s>were analyzed separately and in combination.</s><s>To estimate the independent effect of risk factors on the occurrence of cSCC or BCC, a Cox model was used.</s><s>Second and subsequent cSCCs or BCCs were not considered, because these data were not collected.The starting date for analysis was the day of transplantation; the end dates for those not diagnosed with cSCC or BCC were the end of follow-up or death.</s><s>Proportionality of the hazard was assessed by plotting Schoenfeld residuals for relevant covariates and by introducing interactions of relevant covariates with time in the Cox model.</s><s>A value of P &lt; .05</s><s>indicated a violation of the proportionality assumption.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>8 and 13 .</head><label>813</label><figDesc><div><p><s>4 years, respectively.</s><s>At the end of follow-up, 161 (26%) of 626 OTRs had died: 52 (19%) of 274 OTRs in cohort 1 and 109 (31%) of 352 OTRs in cohort 2.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>1</head><label>1</label><figDesc><div><p><s>Cumulative incidence of cutaneous squamous cell carcinoma in organ-transplant recipients with 5 and more HPV types in eyebrow hair measured 12 mo post-transplant in cohort 1 and after a median of 10 years post-transplant in cohort 2 (red line) compared with transplant recipients with 0-4 HPV types (black line) (Panel A); with a high βPV load in plucked eyebrow hair (red line) compared with transplant recipients with a low load or absence of these 8 specific βPV types (black line) (Panel B); with a positive serologic response to βPV (red line) compared with transplant recipients without a positive response (black line) (Panel C); with a positive serologic response to βPV in combination with the same βPV type(s) in the eyebrow hair (green line), and with a positive serologic response to βPV in combination with different βPV types in the eyebrow hair (red line) compared with transplant recipients without a positive response (black line) (Panel D).</s><s>The curves are adjusted for competitive risk of death and for delayed inclusion of the patients.</s><s>Due to the delayed inclusion, the numbers of patients at risk initially increase with time before they decrease [Color figure can be viewed at wileyonlinelibrary.com] since transplantation Cumulative Incidence of squamous cell carcinoma sero−neg sero−pos−disc sero−pos−conc</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>1</head><label></label><figDesc><div><p><s>Baseline characteristics of the 626 organ transplant recipients</s></p></div></figDesc><table><row><cell></cell><cell>Cohort 1</cell><cell>Cohort 2</cell><cell>Combined cohort</cell></row><row><cell>No. of patients</cell><cell>274</cell><cell>352</cell><cell>626</cell></row><row><cell>Years of first transplantation</cell><cell>2003-2006</cell><cell>1986-2002</cell><cell>1986-2006</cell></row><row><cell>Study center, n (%)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Leiden (The Netherlands)</cell><cell>101 (36.9)</cell><cell>91 (25.9)</cell><cell>192 (30.7)</cell></row><row><cell>Lyon (France)</cell><cell>99 (36.1)</cell><cell>64 (18.2)</cell><cell>163 (26.0)</cell></row><row><cell>London (UK)</cell><cell>32 (11.7)</cell><cell>123 (34.9)</cell><cell>155 (24.8)</cell></row><row><cell>Bergamo (Italy)</cell><cell>42 (15.3)</cell><cell>74 (21.0)</cell><cell>116 (18.5)</cell></row><row><cell></cell><cell></cell><cell></cell><cell>P &lt; .001</cell></row><row><cell>Sex, n (%)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Women</cell><cell>98 (35.8)</cell><cell>96 (27.3)</cell><cell>194 (31.0)</cell></row><row><cell>Men</cell><cell>176 (64.2)</cell><cell>256 (72.7)</cell><cell>432 (69.0)</cell></row><row><cell></cell><cell></cell><cell></cell><cell>P = .023</cell></row><row><cell>Age at transplantation, y</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Median</cell><cell>56.4</cell><cell>50.3</cell><cell>52.4</cell></row><row><cell>IQR (25%-75%)</cell><cell>47.9-62.6</cell><cell>38.4-57.3</cell><cell>42.0-58.9</cell></row><row><cell></cell><cell></cell><cell></cell><cell>P = .003</cell></row><row><cell>Age at physical examination, y</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Median</cell><cell>56.4</cell><cell>59.8</cell><cell>58.2</cell></row><row><cell>IQR (25%-75%)</cell><cell>48.0-62.6</cell><cell>52.7-67.1</cell><cell>51.3-65.7</cell></row><row><cell></cell><cell></cell><cell></cell><cell>P &lt; .001</cell></row><row><cell>Skin phototype, n (%)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Dark/olive</cell><cell>157 (57.5)</cell><cell>162 (46.0)</cell><cell>319 (51.1)</cell></row><row><cell>Medium</cell><cell>91 (33.3)</cell><cell>128 (36.4)</cell><cell>219 (35.0)</cell></row><row><cell>Fair</cell><cell>25 (9.2)</cell><cell>62 (17.6)</cell><cell>87 (13.9)</cell></row><row><cell>Missing values</cell><cell>(1)</cell><cell></cell><cell>P = .002</cell></row><row><cell>Type of organ, n (%)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Kidney</cell><cell>220 (80.3)</cell><cell>288 (81.9)</cell><cell>508 (81.2)</cell></row><row><cell>Kidney and pancreas</cell><cell>34 (12.4)</cell><cell>29 (8.2)</cell><cell>63 (10.0)</cell></row><row><cell>Heart</cell><cell>20 (7.3)</cell><cell>35 (9.9)</cell><cell>55 (8.8)</cell></row><row><cell></cell><cell></cell><cell></cell><cell>P = .140</cell></row><row><cell>Immunosuppressive therapy, n (%)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Aza in any combination</cell><cell>14 (5.1)</cell><cell>148 (42.0)</cell><cell>162 (25.9)</cell></row><row><cell>MMF in any combination</cell><cell>251 (92.0)</cell><cell>108 (30.7)</cell><cell>359 (57.5)</cell></row><row><cell>CyA or Tac without Aza or MMF</cell><cell>8 (2.9)</cell><cell>96 (27.3)</cell><cell>104 (16.6)</cell></row><row><cell>Missing values</cell><cell>(1)</cell><cell></cell><cell>P &lt; .001</cell></row><row><cell>Average daily sun exposure, n (%)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>1-3 h</cell><cell>175 (63.9)</cell><cell>208 (59.1)</cell><cell>383 (61.2)</cell></row><row><cell>≥4 h</cell><cell>99 (36.1)</cell><cell>144 (40.9)</cell><cell>243 (38.8)</cell></row><row><cell></cell><cell></cell><cell></cell><cell>P = .224</cell></row><row><cell>Sunburns before the age of 20 y, n (%)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>0</cell><cell>110 (40.4)</cell><cell>174 (49.4)</cell><cell>284 (45.5)</cell></row><row><cell>1-4</cell><cell>108 (39.7)</cell><cell>123 (34.9)</cell><cell>231 (37.0)</cell></row><row><cell>≥5</cell><cell>54 (19.9)</cell><cell>55 (15.6)</cell><cell>109 (17.5)</cell></row><row><cell>Missing values</cell><cell>(2)</cell><cell></cell><cell>P = .073</cell></row><row><cell></cell><cell></cell><cell></cell><cell>(Continues)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc><div><p><s>The P-values refer to the differences between cohorts 1 and 2 and are calculated with a χ 2 test (ordinal data) or ANOVA (continuous data).</s><s>Significant P-values are indicated in bold.</s><s>Possible risk factors for the development of cutaneous squamous cell carcinoma in 626 organ transplant recipients (combined cohort)</s></p></div></figDesc><table><row><cell></cell><cell>Cohort 1</cell><cell>Cohort 2</cell><cell>Combined cohort</cell></row><row><cell>Smoking, n (%)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>No</cell><cell>139 (50.8)</cell><cell>133 (38.1)</cell><cell>272 (43.7)</cell></row><row><cell>1-19 pack-y</cell><cell>76 (27.7)</cell><cell>136 (39.0)</cell><cell>212 (34.0)</cell></row><row><cell>≥20 pack-y</cell><cell>59 (21.5)</cell><cell>80 (22.9)</cell><cell>139 (22.3)</cell></row><row><cell>Missing values</cell><cell></cell><cell>(3)</cell><cell>P = .003</cell></row><row><cell>Alcohol consumption, n (%)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>No</cell><cell>112 (57.1)</cell><cell>98 (27.8)</cell><cell>210 (38.3)</cell></row><row><cell>1-19 g/d</cell><cell>64 (32.7)</cell><cell>188 (53.4)</cell><cell>252 (56.0)</cell></row><row><cell>≥20 g/d</cell><cell>20 (10.2)</cell><cell>66 (18.8)</cell><cell>86 (15.7)</cell></row><row><cell>Missing values</cell><cell>(78)</cell><cell></cell><cell>P &lt; .001</cell></row><row><cell>Keratotic skin lesions, n (%)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>0</cell><cell>205 (74.8)</cell><cell>111 (31.6)</cell><cell>316 (50.6)</cell></row><row><cell>1-49</cell><cell>65 (23.7)</cell><cell>208 (59.3)</cell><cell>273 (43.6)</cell></row><row><cell>≥50</cell><cell>4 (1.5)</cell><cell>32 (9.1)</cell><cell>36 (5.8)</cell></row><row><cell>Missing values</cell><cell></cell><cell>(1)</cell><cell>P &lt; .001</cell></row><row><cell>Common viral warts, n (%)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>0</cell><cell>234 (85.7)</cell><cell>203 (57.8)</cell><cell>437 (70.0)</cell></row><row><cell>1-49</cell><cell>33 (12.1)</cell><cell>103 (29.3)</cell><cell>136 (21.8)</cell></row><row><cell>≥50</cell><cell>6 (2.2)</cell><cell>45 (12.8)</cell><cell>51 (8.2)</cell></row><row><cell>Missing values</cell><cell>(1)</cell><cell>(1)</cell><cell>P &lt; .001</cell></row><row><cell>No. of βPV types in hair</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Median</cell><cell>4.5</cell><cell>4.0</cell><cell>4.0</cell></row><row><cell>IQR (25%-75%)</cell><cell>2.3-6.8</cell><cell>2.0-8.0</cell><cell>2.0-7.0</cell></row><row><cell></cell><cell></cell><cell></cell><cell>P = .643</cell></row><row><cell>No. of βPV types in hair</cell><cell></cell><cell></cell><cell></cell></row><row><cell>0-4</cell><cell>142 (51.8)</cell><cell>174 (49.4)</cell><cell>316 (50.5)</cell></row><row><cell>≥5</cell><cell>132 (48.2)</cell><cell>178 (50.6)</cell><cell>310 (49.5)</cell></row><row><cell></cell><cell></cell><cell></cell><cell>P = .552</cell></row><row><cell>βPV load (based on 8 βPV types)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Low load (1 copy per ≥20 cells)</cell><cell>195 (71.2)</cell><cell>252 (71.6)</cell><cell>447 (71.4)</cell></row><row><cell>High load (1 copy per &lt;20 cells)</cell><cell>79 (28.8)</cell><cell>100 (28.4)</cell><cell>179 (28.6)</cell></row><row><cell></cell><cell></cell><cell></cell><cell>P = .907</cell></row><row><cell>HPV seropositivity</cell><cell></cell><cell></cell><cell></cell></row><row><cell>αPV</cell><cell>165 (60.2)</cell><cell>188 (53.4)</cell><cell>353 (56.4)</cell></row><row><cell>βPV</cell><cell>137 (50.0)</cell><cell>176 (50.0)</cell><cell>313 (50.0)</cell></row><row><cell>γPV</cell><cell>133 (48.5)</cell><cell>165 (46.9)</cell><cell>298 (47.6)</cell></row><row><cell>μPV</cell><cell>91 (33.2)</cell><cell>100 (28.4)</cell><cell>192 (30.5)</cell></row><row><cell>νPV</cell><cell>31 (11.3)</cell><cell>31 (8.8)</cell><cell>62 (9.9)</cell></row><row><cell></cell><cell></cell><cell></cell><cell>P &gt; .05</cell></row></table><note><p><s>shows the cause-specific HRs for prognostic factors associated with cSCC in the 2 cohorts combined.Results generated from individual cohort analyses are comparable (TablesS1 and S2).Male sex, increasing age, fair skin type, and immunosuppression with azathioprine were the strongest risk factors for cSCC.Because the Aza, azathioprine; CyA, cyclosporin A; MMF, mycophenolate mofetil; Tac, tacrolimus.T A B L E 1 (Continued)T A B L E 2</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>22 (0.13-0.38) 0.28 (0.15-0.50)</head><label></label><figDesc></figDesc><table><row><cell>CyA or Tac without Aza or MMF</cell><cell>93 (17.4)</cell><cell>11 (12.2)</cell><cell>0.</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>33 (0.17-0.64) 0.25 (0.13-0.50)</head><label></label><figDesc></figDesc><table><row><cell>Missing values</cell><cell>(1)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Average daily sun exposure, n (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>1-3 h</cell><cell>335 (62.5)</cell><cell>48 (53.3)</cell><cell>1</cell><cell>1</cell></row><row><cell>≥4 h</cell><cell>201 (37.5)</cell><cell>42 (46.7)</cell><cell>1.4 (0.90-2.1)</cell><cell>1.1 (0.71-1.7)</cell></row><row><cell>Sunburns before the age of 20 y, n (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>0</cell><cell>243 (45.4)</cell><cell>41 (46.1)</cell><cell>1</cell><cell>1</cell></row><row><cell>1-4</cell><cell>196 (36.7)</cell><cell>35 (39.3)</cell><cell>1.1 (0.68-1.7)</cell><cell>0.91 (0.56-1. 5)</cell></row><row><cell>≥5</cell><cell>96 (17.9)</cell><cell>13 (14.6)</cell><cell>0.92 (0.49-1.7)</cell><cell>0.66 (0.33-1.3)</cell></row><row><cell>Missing values</cell><cell>(1)</cell><cell>(1)</cell><cell></cell><cell></cell></row><row><cell>Smoking, n (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>No</cell><cell>240 (44.9)</cell><cell>32 (36.0)</cell><cell>1</cell><cell>1</cell></row><row><cell>1-19 pack-y</cell><cell>182 (34.1)</cell><cell>30 (33.7)</cell><cell>1.1 (0.69-1.9)</cell><cell>0.94 (0.56-1.6)</cell></row><row><cell>≥20 pack-y</cell><cell>112 (21.0)</cell><cell>27 (30.3)</cell><cell>1.9 (1.1-3.2)</cell><cell>1.1 (0.65-1.9)</cell></row><row><cell>Missing values</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head></head><label></label><figDesc><div><p><s>T A B L E 3 Risk of cutaneous squamous cell carcinoma in organ transplant recipients with human papillomavirus infection according to the presence of βPV DNA and/or serologic response to βPV</s></p></div></figDesc><table><row><cell>No. of squamous cell carcinoma</cell><cell>Cohort 1</cell><cell>Cohort 2</cell><cell></cell><cell cols="2">Both cohorts combined</cell></row><row><cell>cases/total population a</cell><cell>14/274</cell><cell>76/352</cell><cell></cell><cell>90/626</cell><cell></cell></row><row><cell></cell><cell>Cause-specific</cell><cell>Cause-specific</cell><cell></cell><cell>Cause-specific</cell><cell></cell></row><row><cell>Risk factors</cell><cell>univariate HR b</cell><cell>univariate HR</cell><cell>Adjusted HR c</cell><cell>univariate HR</cell><cell>Adjusted HR c</cell></row><row><cell>βPV DNA (based on 25 βPV types)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>0-4 types</cell><cell>1</cell><cell>1</cell><cell>1</cell><cell>1</cell><cell>1</cell></row><row><cell>≥5</cell><cell>2.6 (0.82-8.3)</cell><cell>1.8 (1.1-2.8)</cell><cell>1.6 (0.998-2.7)</cell><cell>1.9 (1.2-2.9)</cell><cell>1.7 (1.1-2.6)</cell></row><row><cell>βPV load (based on 8 βPV types)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Low load (1 copy per ≥20 cells)</cell><cell>1</cell><cell>1</cell><cell>1</cell><cell>1</cell><cell>1</cell></row><row><cell>High load (1 copy per &lt;20 cells)</cell><cell>4.6 (1.5-13.8)</cell><cell>1.8 (1.1-2.8)</cell><cell>1.5 (0.92-2.4)</cell><cell>2.1 (1.4-3.1)</cell><cell>1.8 (1.2-2.8)</cell></row><row><cell>βPV serology (based on 16 βPV types)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Seronegative</cell><cell>1</cell><cell>1</cell><cell>1</cell><cell>1</cell><cell>1</cell></row><row><cell>Seropositive</cell><cell>1.0 (0.36-2.9)</cell><cell>1.6 (1.02-2.6)</cell><cell>1.5 (0.90-2.4)</cell><cell>1.5 (0.97-2.3)</cell><cell>1.4 (0.90-2.1)</cell></row><row><cell>Combination βPV DNA and serology</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Seronegative irrespective DNA</cell><cell>1</cell><cell>1</cell><cell>1</cell><cell>1</cell><cell>1</cell></row><row><cell>Seropositive without concordant</cell><cell>0.98 (0.25-3.9)</cell><cell>1.2 (0.69-2.2)</cell><cell>1.2 (0.66-2.2)</cell><cell>1.2 (0.69-2.0)</cell><cell>1.2 (0.71-2.1)</cell></row><row><cell>DNA</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Seropositive with concordant DNA</cell><cell>1.1 (0.31-3.6)</cell><cell>2.0 (1.2-3.3)</cell><cell>1.7 (1.002-3.0)</cell><cell>1.8 (1.1-2.9)</cell><cell>1.5 (0.93-2.5)</cell></row><row><cell>γPV serology (based on 6 γPV types)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Seronegative</cell><cell>1</cell><cell>1</cell><cell>1</cell><cell>1</cell><cell>1</cell></row><row><cell>Seropositive</cell><cell>1.1 (0.38-3.1)</cell><cell>1.5 (0.93-2.3)</cell><cell>1.7 (1.1-2.8)</cell><cell>1.4 (0.91-2.1)</cell><cell>1.6 (1.01-2.4)</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head><p><s>The first part of the study was funded by an EU 5FP collaborative research grant (QLK2-CT-2002-0117).</s><s>D.A., F.S., and the other group members of IDI-IRCCS FLMM were also supported, in part, by the "Progetto Ricerca Corrente" of the Italian Ministry of Health, Rome, Italy.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>AUTHOR CONTRIBUTIONS</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Skin cancers after organ transplantation</title>
		<author>
			<persName><forename type="first">S</forename><surname>Euvrard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kanitakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Claudy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">348</biblScope>
			<biblScope unit="page" from="1681" to="1691" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Incidence of skin cancer after renal transplantation in The Netherlands</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Hartevelt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bouwes</forename><surname>Bavinck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Kootte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Vermeer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Vandenbroucke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Transplantation</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="506" to="509" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands</title>
		<author>
			<persName><forename type="first">Bouwes</forename><surname>Bavinck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Euvrard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Naldi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Invest Dermatol</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="1647" to="1656" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">The molecular revolution in cutaneous biology: investigating the skin microbiome</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Kong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Segre</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Invest Dermatol</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="page" from="e119" to="e122" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Biogeography and individuality shape function in the human skin metagenome</title>
		<author>
			<persName><forename type="first">J</forename><surname>Oh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Byrd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Deming</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">514</biblScope>
			<biblScope unit="page" from="59" to="64" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Human skin microbiota: high diversity of DNA viruses identified on the human skin by high throughput sequencing</title>
		<author>
			<persName><forename type="first">V</forename><surname>Foulongne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Sauvage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hebert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e38499</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Human papillomavirus community in healthy persons, defined by metagenomics analysis of human microbiome project shotgun sequencing data sets</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Madupu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Karaoz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Virol</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="4786" to="4797" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Human papillomavirus molecular biology and disease association</title>
		<author>
			<persName><forename type="first">J</forename><surname>Doorbar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Egawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Griffin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kranjec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Murakami</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rev Med Virol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="2" to="23" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Beta genus papillomaviruses and skin cancer</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Howley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Pfister</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Virology</title>
		<imprint>
			<biblScope unit="page" from="290" to="296" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Five-year cervical (pre)cancer risk of women screened by HPV and cytology testing</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Uijterwaal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Polman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Van Kemenade</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Prev Res (Phila)</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="502" to="508" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Cutaneous HPV and skin cancer</title>
		<author>
			<persName><forename type="first">R</forename><surname>Accardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gheit</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Presse Med</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="e435" to="e443" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Association between beta-genus human papillomavirus and cutaneous squamous cell carcinoma in immunocompetent individuals-a meta-analysis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Chahoud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Semaan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA Dermatol</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page">1354</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Milk of human kindness?-HAMLET, human papillomavirus, and warts</title>
		<author>
			<persName><forename type="first">Bouwes</forename><surname>Bavinck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Feltkamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">350</biblScope>
			<biblScope unit="page" from="2639" to="2642" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control</title>
		<author>
			<persName><forename type="first">K</forename><surname>Connolly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Manders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Earls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Epstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Treat Rev</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="205" to="214" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Human Betapapillomavirus infection and keratinocyte carcinomas</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Quint</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Genders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>De Koning</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pathol</title>
		<imprint>
			<biblScope unit="volume">235</biblScope>
			<biblScope unit="page" from="342" to="354" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Spontaneous tumour development in human papillomavirus type 8 E6 transgenic mice and rapid induction by UV-light exposure and wounding</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Marcuzzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hufbauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">U</forename><surname>Kasper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Weissenborn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Smola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Pfister</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Gen Virol</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="2855" to="2864" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice</title>
		<author>
			<persName><forename type="first">D</forename><surname>Viarisio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mueller-Decker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Kloz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Pathog</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e1002125</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Betapapillomaviruses frequently persist in the skin of healthy individuals</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>De Koning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Struijk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bouwes</forename><surname>Bavinck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Gen Virol</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="1489" to="1495" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>De Koning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Weissenborn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Abeni</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Gen Virol</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="1611" to="1621" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Case-control study of genusbeta human papillomaviruses in plucked eyebrow hairs and cutaneous squamous cell carcinoma</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Iannacone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gheit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Pfister</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="page" from="2231" to="2244" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma</title>
		<author>
			<persName><forename type="first">Bouwes</forename><surname>Bavinck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Neale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Abeni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="9777" to="9786" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Karagas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Waterboer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">341</biblScope>
			<biblScope unit="page">2986</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Prospective study of human papillomavirus seropositivity and risk of nonmelanoma skin cancer</title>
		<author>
			<persName><forename type="first">K</forename><surname>Andersson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Michael</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Luostarinen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">175</biblScope>
			<biblScope unit="page" from="685" to="695" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: a population-based study</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Farzan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Waterboer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gui</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="1713" to="1720" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">A case-control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Proby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Harwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Neale</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Transplant</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1498" to="1508" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">The presence of betapapillomavirus antibodies around transplantation predicts the development of keratinocyte carcinoma in organ transplant recipients: a cohort study</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Genders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mazlom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Michel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Invest Dermatol</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="1275" to="1282" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Seropositivity for human papillomavirus and incidence of subsequent squamous cell and basal cell carcinomas of the skin in patients with a previous nonmelanoma skin cancer</title>
		<author>
			<persName><forename type="first">A</forename><surname>Paradisi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Waterboer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Sampogna</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Dermatol</title>
		<imprint>
			<biblScope unit="volume">165</biblScope>
			<biblScope unit="page" from="782" to="791" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">The Association between cutaneous squamous cell carcinoma and betapapillomavirus seropositivity: a cohort study</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">I</forename><surname>Plasmeijer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Pandeya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>O'rourke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="1171" to="1177" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Iannacone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gheit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Waterboer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="1303" to="1313" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Sunlight exposure and cutaneous human papillomavirus seroreactivity in basal cell and mous cell carcinomas of the skin</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Iannacone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">G</forename><surname>Stockwell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">206</biblScope>
			<biblScope unit="page" from="399" to="406" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Cutaneous human papillomaviruses and squamous cell carcinoma of the skin: nested case-control study</title>
		<author>
			<persName><forename type="first">H</forename><surname>Faust</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Andersson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Luostarinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Gislefoss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dillner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="721" to="724" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Human papillomavirus load in eyebrow hair follicles and risk of cutaneous squamous cell carcinoma</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Neale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Weissenborn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Abeni</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="719" to="727" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Deep sequencing extends the diversity of human papillomaviruses in human skin</title>
		<author>
			<persName><forename type="first">D</forename><surname>Bzhalava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Muhr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lagheden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci Rep</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">5807</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Human papillomavirus type 197 is commonly present in skin tumors</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Arroyo Muhr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hultin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bzhalava</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page" from="2546" to="2555" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Longitudinal study of seroprevalence and serostability of 34 human papillomavirus types in European organ transplant recipients</title>
		<author>
			<persName><forename type="first">A</forename><surname>Antonsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Waterboer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bouwes</forename><surname>Bavinck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Virology</title>
		<imprint>
			<biblScope unit="volume">436</biblScope>
			<biblScope unit="page" from="91" to="99" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Evaluation of a novel highly sensitive, broad-spectrum PCR-reverse hybridization assay for detection and identification of beta-papillomavirus DNA</title>
		<author>
			<persName><forename type="first">M</forename><surname>De Koning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Quint</forename><forename type="middle">W</forename><surname>Struijk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="1792" to="1800" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Seroprevalence of 34 human papillomavirus types in the German general population</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Michael</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Waterboer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Sehr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Pathog</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">e1000091</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins</title>
		<author>
			<persName><forename type="first">T</forename><surname>Waterboer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Sehr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Michael</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="1845" to="1853" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Revision surgery is overestimated in hip replacement</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Keurentjes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fiocco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Schreurs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Pijls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Nouta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Nelissen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bone Joint Res</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="258" to="262" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Tutorial in biostatistics: competing risks and multi-state models</title>
		<author>
			<persName><forename type="first">H</forename><surname>Putter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fiocco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Geskus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stat Med</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="2389" to="2430" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Overadjustment bias and unnecessary adjustment in epidemiologic studies</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Schisterman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Cole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Platt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Epidemiology</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="488" to="495" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">The mstate package for estimation and prediction in non-and semi-parametric multi-state and competing risks models</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>De Wreede</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fiocco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Putter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Comput Methods Programs Biomed</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="261" to="274" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Viral oncogenesis and its role in nonmelanoma skin cancer</title>
		<author>
			<persName><forename type="first">Arron</forename><surname>St</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Jennings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Nindl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Dermatol</title>
		<imprint>
			<biblScope unit="volume">164</biblScope>
			<biblScope unit="page" from="1201" to="1213" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Beta-papillomavirus DNA loads in hair follicles of immunocompetent people and organ transplant recipients</title>
		<author>
			<persName><forename type="first">S</forename><surname>Weissenborn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Neale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Waterboer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Microbiol Immunol</title>
		<imprint>
			<biblScope unit="volume">201</biblScope>
			<biblScope unit="page" from="117" to="125" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Proteomic analysis of the gamma human papillomavirus type 197 E6 and E7 associated cellular proteins</title>
		<author>
			<persName><forename type="first">M</forename><surname>Grace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Munger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Virology</title>
		<imprint>
			<biblScope unit="volume">500</biblScope>
			<biblScope unit="page" from="71" to="81" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: A multicenter, prospective cohort study</title>
		<author>
			<persName><forename type="first">Bouwes</forename><surname>Bavinck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Feltkamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mcw</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename></persName>
		</author>
		<idno type="DOI">10.1111/ajt.14537</idno>
		<ptr target="https://doi.org/10.1111/ajt.14537" />
	</analytic>
	<monogr>
		<title level="j">Am J Transplant</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="1220" to="1230" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">G L</forename><surname>Kralt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>De Graaf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Vos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Uphoff-Meijerink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Halk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sneek</surname></persName>
		</author>
		<author>
			<persName><surname>Willemze</surname></persName>
		</author>
		<editor>M. C. W.</editor>
		<imprint>
			<pubPlace>Leiden, The Netherlands</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Department of Medical Microbiology, Leiden University Medical Center</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">L</forename><surname>Feltkamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Struijk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Wanningen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">I</forename><surname>Van Der Meijden</surname></persName>
		</author>
		<author>
			<persName><surname>Plasmeijer</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<author>
			<persName><forename type="first">S</forename><surname>Euvrard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C M A</forename><surname>Ocampo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kanitakis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Azienda Ospedaliera papa Giovanni XXIII, and GISED Study Center</title>
				<editor>
			<persName><forename type="first">L</forename><surname>Naldi</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">A</forename><surname>Pizzagalli</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">F</forename><surname>Sassi</surname></persName>
		</editor>
		<meeting><address><addrLine>Lyon, France; Berlin, Germany; Bergamo, Italy</addrLine></address></meeting>
		<imprint/>
		<respStmt>
			<orgName>Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands: R. Wolterbeek; Department of Dermatology, Hospices Civils de Lyon ; Department of Dermatology, University Hospital Charité</orgName>
		</respStmt>
	</monogr>
	<note>Department of Dermatology</note>
</biblStruct>

<biblStruct xml:id="b49">
	<monogr>
		<title level="m" type="main">Centre for Cutaneous Research, Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry</title>
		<author>
			<persName><forename type="first">R</forename><surname>Gotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C D</forename><surname>Fiocchi</surname></persName>
		</author>
		<author>
			<persName><surname>Diphoorn</surname></persName>
		</author>
		<editor>C. A. Harwood, C. M. Proby, J. Breuer, L. Mitchell, K. Purdie, S. R. Lambert, H. Ran</editor>
		<imprint>
			<pubPlace>Verona, Italy; London, UK</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Department of Biomedical and Surgical Sciences, Section of Dermatology, University of Verona, c/o Ospedale Civile Maggiore ; Queen Mary University of London</orgName>
		</respStmt>
	</monogr>
	<note>Institute of</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Virology</title>
		<imprint/>
		<respStmt>
			<orgName>University of Cologne</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Wieland</surname></persName>
		</author>
		<author>
			<persName><surname>Weissenborn; German Cancer Research</surname></persName>
		</author>
		<author>
			<persName><surname>Center</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<monogr>
		<title/>
		<author>
			<persName><surname>Heidelberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">:</forename><forename type="middle">M</forename><surname>Germany</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Pawlita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Waterboer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Sehr</surname></persName>
		</author>
		<author>
			<persName><surname>Michael</surname></persName>
		</author>
		<imprint>
			<publisher>W</publisher>
			<pubPlace>Rijswijk, The Netherlands</pubPlace>
		</imprint>
		<respStmt>
			<orgName>DDL Diagnostic Laboratory</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">V</forename><surname>Quint</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N C</forename><surname>De Koning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">*</forename></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schegget</surname></persName>
		</author>
		<author>
			<persName><forename type="first">*</forename></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kleter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Van</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">D</forename><surname>Abeni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Sampogna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Simoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Petasecca Donati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Masini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Epidemiology Unit, IDI-IRCCS</title>
		<editor>A. C. Green, R. E.</editor>
		<imprint/>
		<respStmt>
			<orgName>Doorn. *Also employed by Department of Medical Microbiology, Leiden University Medical Center ; Queensland Institute of Medical Research</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">P</forename><surname>Olsen</surname></persName>
		</author>
		<author>
			<persName><surname>O'rourke</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Harrison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Buttner</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
